首页|倍他司汀结合鼓室注射甲泼尼龙在突发性耳聋治疗中的作用

倍他司汀结合鼓室注射甲泼尼龙在突发性耳聋治疗中的作用

扫码查看
目的 探讨倍他司汀结合鼓室注射甲泼尼龙治疗在突发性耳聋治疗中的应用效果.方法 选取2021年1月-2023年5月北京市密云区医院收治的92例突发性耳聋患者作为研究对象.随机分为研究组(n=46)和对照组(n=46),对照组采用倍他司汀治疗,研究组在倍他司汀治疗基础上给予鼓室注射甲泼尼龙.比较2组患者临床疗效、治疗前后听力阈值和血液流变学指标以及不良反应发生情况.结果 研究组患者治疗总有效率为95.65%,对照组为76.09%,差异有统计学意义(x2=8.265,P=0.016).治疗前2组患者听力阈值差异无统计学意义(P>0.05);治疗后研究组患者 1、2、4 kHz 听力阈值[(45.11±4.26)、(43.73±4.65)、(53.33±5.65)]dB 高于对照组[(55.39±5.09)、(57.26±5.64)、(62.78±6.46)]dB,差异有统计学意义(t=10.504、12.554、7.468,P均<0.05).治疗后研究组患者PV(1.52±0.18)mPa·s、HSV(4.55±0.37)mPa·s 和LSV(7.06±0.75)mPa·s,对照组分别为(1.92±0.26、5.58±0.53、9.85±0.98)mPa·s,差异均有统计学意义(P均<0.05).研究组患者并发症发生率(4.35%)和对照组(6.52%)比较,差异无统计学意义(x2=0.211,P=0.646).结论 倍他司汀结合鼓室注射甲泼尼龙治疗突发性耳聋可改善患者听力阈值,减轻不良反应,值得临床进一步推广应用.
Clinical effects of injection of betahistine combined with methylpredniso-lone into the tympanum on sudden deafness and hearing
Objective The clinical effects of injection of betahistine combined with methylprednisolone into the tympanum on sudden deafness and hearing are discussed,according to clinical experience.Methods Ninety-two patients with sudden deafness admitted to the Miyun District Hospital in Beijing between January 2021 and May 2023 were randomly divided into a study group(n=46)and control group(n=46).The control group received betahistine,and the study group received methylprednisone injection into the tympanum on the basis of betahistine treatment.The clinical efficacy,hearing threshold,and hemorheology indexes before and after treatment,and the occurrence of adverse reactions were compared between groups.Results The total effectiveness rate was 95.65%in the study group and 76.09%in the control group;the difference was statistically significant(x2=8.265,P=0.016).No significant difference in the hearing threshold was observed between groups before treatment(P>0.05).After treatment,the 1,2,and 4 kHz hearing thresholds were higher in the study group(45.11±4.26,43.73±4.65,and 53.33±5.65 dB,respectively)than the control group(55.39±5.09,57.26±5.64,and 62.78±6.46 dB,respectively),and the difference was statistically significant(t=10.504,12.554,and 7.468,respectively;all P<0.05).After treatment,PV,HSV,and LSV were 1.52±0.18,4.55±0.37,and 7.06±0.75 mPa·s,respectively,in the in the study group,and 1.92±0.26,5.58±0.53,and 9.85±0.98 mPa·s,respectively,in the control group.The difference was statisti-cally significant(all P<0.05).No significant difference in complication rates was observed between the study group(4.35%)and the control group(6.52%)(x2=0.211,P=0.646).Conclusion Betahistine combined with methylprednisone injection in-to the tympanum for treatment of sudden deafness significantly improves the hearing threshold in patients and decreases ad-verse reactions,and therefore is worthy of further clinical application.

BetahistineMethylprednisolone injec-tion into tympanic cavitySudden deafness

钱丽芳、王黎明

展开 >

北京市密云区医院耳鼻喉科,北京 101500

倍他司汀 鼓室注射甲泼尼龙 突发性耳聋

2024

中国校医
江苏省预防医学会 中华预防医学会

中国校医

影响因子:0.378
ISSN:1001-7062
年,卷(期):2024.38(10)